• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧诱导因子 2α(HIF2α)诱导 RNASET2 的上调促进了透明细胞肾细胞癌(ccRCC)中的甘油三酯合成并增强了细胞迁移。

HIF2α-induced upregulation of RNASET2 promotes triglyceride synthesis and enhances cell migration in clear cell renal cell carcinoma.

机构信息

Department of Histology, Embryology, Genetics and Developmental Biology, Shanghai Key Laboratory for Reproductive Medicine, Shanghai Jiao Tong University School of Medicine, China.

Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China.

出版信息

FEBS Open Bio. 2023 Apr;13(4):638-654. doi: 10.1002/2211-5463.13570. Epub 2023 Feb 12.

DOI:10.1002/2211-5463.13570
PMID:36728187
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10068329/
Abstract

Clear cell renal cell carcinoma (ccRCC), the most common malignant subtype of renal cell carcinoma, is characterized by the accumulation of lipid droplets in the cytoplasm. RNASET2 is a protein coding gene with a low expression level in ovarian cancers, but it is overexpressed in poorly differentiated neuroendocrine carcinomas. There is a correlation between RNASET2 upregulation and triglyceride expression levels in human serum but is unknown whether such an association is a factor contributing to lipid accumulation in ccRCC. Herein, we show that RNASET2 expression levels in ccRCC tissues and cell lines are significantly higher than those in both normal adjacent tissues and renal tubular epithelial cells. Furthermore, its upregulation is associated with increases in ccRCC malignancy and declines in patient survival. We also show that an association exists between increases in both cytoplasmic lipid accumulation and HIF-2α transcription factor upregulation, and increases in both RNASET2 and triglyceride expression levels in ccRCC tissues. In addition, DGAT1 and DGAT2, two key enzymes involved in triglyceride synthesis, are highly expressed in ccRCC tissues. By contrast, RNASET2 knockdown inhibited their expression levels and lowered lipid droplet accumulation, as well as suppressing in vitro cell proliferation, cell invasion, and migration. In conclusion, our data suggest HIF2α upregulates RNASET2 transcription in ccRCC cells, which promotes both the synthesis of triglycerides and ccRCC migration. As such, RNASET2 may have the potential as a biomarker or target for the diagnosis and treatment of ccRCC.

摘要

透明细胞肾细胞癌(ccRCC)是肾细胞癌中最常见的恶性亚型,其特征是细胞质中脂质滴的积累。RNASET2 是一种蛋白编码基因,在卵巢癌中的表达水平较低,但在低分化神经内分泌癌中过度表达。在人类血清中,RNASET2 的上调与甘油三酯表达水平之间存在相关性,但尚不清楚这种相关性是否是导致 ccRCC 脂质积累的因素之一。在此,我们表明,ccRCC 组织和细胞系中的 RNASET2 表达水平明显高于正常相邻组织和肾小管上皮细胞。此外,其上调与 ccRCC 恶性程度的增加和患者生存的下降有关。我们还表明,ccRCC 组织中细胞质脂质积累和 HIF-2α 转录因子上调的增加与 RNASET2 和甘油三酯表达水平的增加之间存在关联。此外,DGAT1 和 DGAT2,两种参与甘油三酯合成的关键酶,在 ccRCC 组织中高表达。相比之下,RNASET2 敲低抑制了它们的表达水平,降低了脂质滴的积累,并抑制了体外细胞增殖、细胞侵袭和迁移。总之,我们的数据表明,HIF2α 在 ccRCC 细胞中上调 RNASET2 的转录,促进了甘油三酯的合成和 ccRCC 的迁移。因此,RNASET2 可能具有作为 ccRCC 诊断和治疗的生物标志物或靶标的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/defd/10068329/f6f9fca1d005/FEB4-13-638-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/defd/10068329/35d291e36471/FEB4-13-638-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/defd/10068329/1a4361cedfb7/FEB4-13-638-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/defd/10068329/f6f9fca1d005/FEB4-13-638-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/defd/10068329/35d291e36471/FEB4-13-638-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/defd/10068329/1a4361cedfb7/FEB4-13-638-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/defd/10068329/f6f9fca1d005/FEB4-13-638-g001.jpg

相似文献

1
HIF2α-induced upregulation of RNASET2 promotes triglyceride synthesis and enhances cell migration in clear cell renal cell carcinoma.缺氧诱导因子 2α(HIF2α)诱导 RNASET2 的上调促进了透明细胞肾细胞癌(ccRCC)中的甘油三酯合成并增强了细胞迁移。
FEBS Open Bio. 2023 Apr;13(4):638-654. doi: 10.1002/2211-5463.13570. Epub 2023 Feb 12.
2
Pathogenic Roles for RNASET2 in Clear Cell Renal Cell Carcinoma.RNASET2 在肾透明细胞癌中的致病作用。
Lab Invest. 2024 May;104(5):102041. doi: 10.1016/j.labinv.2024.102041. Epub 2024 Feb 29.
3
Systematic analysis of RNASET2 gene as a potential prognostic and immunological biomarker in clear cell renal cell carcinoma.系统分析 RNASET2 基因作为透明细胞肾细胞癌潜在的预后和免疫生物标志物。
BMC Cancer. 2023 Sep 7;23(1):837. doi: 10.1186/s12885-023-11356-6.
4
HIF-2α-induced upregulation of CD36 promotes the development of ccRCC.缺氧诱导因子 2α 诱导的 CD36 上调促进 ccRCC 的发展。
Exp Cell Res. 2022 Dec 15;421(2):113389. doi: 10.1016/j.yexcr.2022.113389. Epub 2022 Oct 15.
5
Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.长链非编码RNA LUCAT1通过AKT/GSK-3β信号通路促进肾透明细胞癌的增殖和侵袭。
Cell Physiol Biochem. 2018;48(3):891-904. doi: 10.1159/000491957. Epub 2018 Jul 20.
6
HIF2α-Dependent Lipid Storage Promotes Endoplasmic Reticulum Homeostasis in Clear-Cell Renal Cell Carcinoma.缺氧诱导因子2α依赖性脂质储存促进透明细胞肾细胞癌的内质网稳态
Cancer Discov. 2015 Jun;5(6):652-67. doi: 10.1158/2159-8290.CD-14-1507. Epub 2015 Mar 31.
7
Upregulation of homeobox D10 expression suppresses invasion and migration of clear cell renal cell carcinoma through targeting of E-cadherin.同源盒蛋白 D10 表达上调通过靶向 E-钙黏蛋白抑制肾透明细胞癌的侵袭和迁移。
Mol Biol Rep. 2022 Mar;49(3):1837-1846. doi: 10.1007/s11033-021-06993-8. Epub 2021 Nov 25.
8
Bromodomain-containing protein 9 is a prognostic biomarker associated with immune infiltrates and promotes tumor malignancy through activating notch signaling pathway in negative HIF-2α clear cell renal cell carcinoma.含溴结构域蛋白9是一种与免疫浸润相关的预后生物标志物,在HIF-2α阴性的透明细胞肾细胞癌中通过激活Notch信号通路促进肿瘤恶性进展。
IUBMB Life. 2021 Nov;73(11):1334-1347. doi: 10.1002/iub.2547. Epub 2021 Aug 29.
9
Follistatin-like protein 1 plays a tumor suppressor role in clear-cell renal cell carcinoma.卵泡抑素样蛋白1在透明细胞肾细胞癌中发挥肿瘤抑制作用。
Chin J Cancer. 2018 Jan 22;37(1):2. doi: 10.1186/s40880-018-0267-2.
10
Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.在透明细胞肾细胞癌中,Dicer表达下调,并且在体外实验中,敲低Dicer可增强恶性表型转化。
Urol Oncol. 2014 Jan;32(1):46.e9-17. doi: 10.1016/j.urolonc.2013.06.011. Epub 2013 Oct 4.

引用本文的文献

1
RNASET2 Deficiency Induces Hepatocellular Carcinoma Metastasis through Cholesterol-Triggered MET Activation.RNASET2缺乏通过胆固醇触发的MET激活诱导肝细胞癌转移。
Adv Sci (Weinh). 2025 Mar;12(12):e2411888. doi: 10.1002/advs.202411888. Epub 2025 Feb 4.
2
Comprehensive analysis of LD-related genes signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.全面分析 LD 相关基因特征,以预测透明细胞肾细胞癌的预后和免疫治疗反应。
BMC Nephrol. 2024 Sep 10;25(1):298. doi: 10.1186/s12882-024-03735-3.
3
Targeting lipid droplets and lipid droplet-associated proteins: a new perspective on natural compounds against metabolic diseases.

本文引用的文献

1
FBXO6-mediated RNASET2 ubiquitination and degradation governs the development of ovarian cancer.FBXO6 介导的 RNASET2 泛素化和降解调控卵巢癌的发生。
Cell Death Dis. 2021 Mar 25;12(4):317. doi: 10.1038/s41419-021-03580-4.
2
Efficacy and Safety of Atezolizumab Plus Bevacizumab Following Disease Progression on Atezolizumab or Sunitinib Monotherapy in Patients with Metastatic Renal Cell Carcinoma in IMmotion150: A Randomized Phase 2 Clinical Trial.在 IMmotion150 研究中,转移性肾细胞癌患者在接受阿特珠单抗或舒尼替尼单药治疗后疾病进展时,接受阿特珠单抗联合贝伐珠单抗治疗的疗效和安全性:一项随机 2 期临床试验。
Eur Urol. 2021 May;79(5):665-673. doi: 10.1016/j.eururo.2021.01.003. Epub 2021 Mar 5.
3
靶向脂滴和脂滴相关蛋白:天然化合物对抗代谢性疾病的新视角。
Chin Med. 2024 Sep 4;19(1):120. doi: 10.1186/s13020-024-00988-w.
4
Lipid droplets: a candidate new research field for epithelial ovarian cancer.脂滴:上皮性卵巢癌一个潜在的新研究领域。
Front Pharmacol. 2024 Jul 1;15:1437161. doi: 10.3389/fphar.2024.1437161. eCollection 2024.
5
Emergence of Lipid Droplets in the Mechanisms of Carcinogenesis and Therapeutic Responses.脂滴在肿瘤发生机制及治疗反应中的出现
Cancers (Basel). 2023 Aug 14;15(16):4100. doi: 10.3390/cancers15164100.
Clear cell renal cell carcinoma ontogeny and mechanisms of lethality.
透明细胞肾细胞癌的发生机制及致死机制。
Nat Rev Nephrol. 2021 Apr;17(4):245-261. doi: 10.1038/s41581-020-00359-2. Epub 2020 Nov 3.
4
Lymph protects metastasizing melanoma cells from ferroptosis.淋巴保护转移黑色素瘤细胞免受铁死亡。
Nature. 2020 Sep;585(7823):113-118. doi: 10.1038/s41586-020-2623-z. Epub 2020 Aug 19.
5
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention.脂类与癌症:在发病机制、诊断和治疗干预中的新作用。
Adv Drug Deliv Rev. 2020;159:245-293. doi: 10.1016/j.addr.2020.07.013. Epub 2020 Jul 23.
6
Expression, Location, Clinical Implication, and Bioinformatics Analysis of RNASET2 in Gastric Adenocarcinoma.RNASET2在胃腺癌中的表达、定位、临床意义及生物信息学分析
Front Oncol. 2020 May 22;10:836. doi: 10.3389/fonc.2020.00836. eCollection 2020.
7
JMY expression by Sertoli cells contributes to mediating spermatogenesis in mice.支持细胞中的 JMY 表达有助于介导小鼠的精子发生。
FEBS J. 2020 Dec;287(24):5478-5497. doi: 10.1111/febs.15328. Epub 2020 Apr 23.
8
3-[(1,2,3)-2,3-Difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977), a Hypoxia-Inducible Factor 2α (HIF-2α) Inhibitor for the Treatment of Clear Cell Renal Cell Carcinoma.3-[(1,2,3)-2,3-二氟-1-羟基-7-甲磺酰基-1H-吲唑-4-基]氧基-5-氟苯甲腈(PT2977),一种缺氧诱导因子 2α(HIF-2α)抑制剂,用于治疗肾透明细胞癌。
J Med Chem. 2019 Aug 8;62(15):6876-6893. doi: 10.1021/acs.jmedchem.9b00719. Epub 2019 Jul 8.
9
GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis.GEPIA2:一个用于大规模表达谱分析和交互式分析的增强型网络服务器。
Nucleic Acids Res. 2019 Jul 2;47(W1):W556-W560. doi: 10.1093/nar/gkz430.
10
The landscape of cancer cell line metabolism.癌细胞系代谢的全景。
Nat Med. 2019 May;25(5):850-860. doi: 10.1038/s41591-019-0404-8. Epub 2019 May 8.